Tycoon Group Holdings Limited (3390) AI Stock Analysis

• Market Cap: HK$277.14M
• Dividend Yield: 22.58%
• Average Volume (3M): 1.45M
• Price to Earnings (P/E): 76.2
• Beta (1Y): -0.07
• Revenue Growth: -1.68%
• EPS Growth: -111.10%
• Country: HK
• Employees: 258
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Pharmaceuticals
• EPS (TTM): -0.01
• Shares Outstanding: 894,000,000
• 10 Day Avg. Volume: 1,519,200
• 30 Day Avg. Volume: 1,447,200
• PEG Ratio: -8.80
• Price to Book (P/B): 5.89
• Price to Sales (P/S): 3.22
• P/FCF Ratio: -35.71
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$0.50
• Price Target Upside: 66.67% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 49 Neutral
• Price Target: HK$0.50 ▲(66.67% Upside)

The overall stock score reflects significant financial challenges, particularly in cash flow and profitability, as well as a concerning valuation with a negative P/E ratio. While the balance sheet shows some stability, the technical analysis indicates a lack of strong momentum. The high dividend yield is a positive, but its sustainability is questionable given the current financial state.

Tycoon Group Holdings Limited Business Overview & Revenue Model

Company Description

Tycoon Group Holdings Limited, an investment holding company, distributes and retails a suite of health and well-being related products in Hong Kong, Mainland China, Macau, and internationally. It operates through three segments: Distribution, E-Commerce, and Retail Stores. The company offers proprietary Chinese medicine, health supplement, skin care, personal care, and other healthcare products under the third-party and private label brands. It sells its products to chain retailers, non-chain retailers, and traders; and through its brick-and-mortar retail stores as well as online stores. The company was founded in 2015 and is headquartered in Shatin, Hong Kong.

How the Company Makes Money

Tycoon Group Holdings Limited generates revenue through its diverse portfolio of healthcare and personal care products, which are distributed via multiple channels including retail chains, e-commerce platforms, and direct sales. The company capitalizes on its strong distribution network and strategic partnerships with major healthcare brands to ensure a broad market reach. Revenue streams include sales from proprietary Chinese medicines, health supplements, and a variety of personal care items. Additionally, the company benefits from economies of scale and extensive market knowledge, which help optimize its supply chain and enhance profitability.

Tycoon Group Holdings Limited Financial Statement Overview

Summary

Tycoon Group Holdings Limited exhibits a mixed financial profile with moderate weaknesses in income and cash flow statements. The income statement shows fluctuating performance with concerns over declining revenue growth and net profit margins. The balance sheet reflects moderate stability but increasing debt levels. Cash flow analysis indicates significant challenges with negative operating cash flow in several years.

Income Statement

The income statement shows fluctuating performance over the past years. The gross profit margin has been relatively stable, but recent declines in revenue growth and net profit margins are concerns. The company has struggled to maintain consistent profitability, with recent net income levels significantly lower compared to past years. This volatility indicates potential challenges in revenue and cost management.

Balance Sheet

The balance sheet reflects moderate stability with a relatively balanced debt-to-equity ratio, but there is a noticeable increase in total debt over the years, raising leverage concerns. Stockholders' equity has been increasing, which is a positive sign, but the equity ratio has been inconsistent. The company's assets have grown, but liabilities have increased at a faster rate, which could pose risks if not managed properly.

Cash Flow

Cash flow analysis indicates significant challenges, particularly with operating cash flow being negative in several years. Free cash flow has also been erratic, with recent negative figures suggesting cash management issues. The operating cash flow to net income ratio indicates inefficiencies in converting income into cash. The company needs to focus on improving cash flow stability to mitigate financial stress.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	876.04M	1.20B	1.19B	888.87M	505.99M
Gross Profit	232.66M	321.10M	243.53M	135.01M	71.06M
EBITDA	35.85M	356.41M	85.26M	5.45M	-49.05M
Net Income	3.24M	297.32M	43.75M	-18.82M	-61.13M
Balance Sheet
Total Assets	1.01B	988.95M	1.01B	881.46M	619.91M
Cash, Cash Equivalents and Short-Term Investments	34.02M	39.10M	74.60M	71.63M	119.34M
Total Debt	330.98M	206.16M	341.60M	239.08M	198.32M
Total Liabilities	516.61M	445.40M	718.96M	620.20M	329.47M
Stockholders Equity	478.85M	536.23M	293.64M	257.92M	288.16M
Cash Flow
Free Cash Flow	-78.94M	7.97M	-64.48M	-50.11M	-119.41M
Operating Cash Flow	-76.62M	11.86M	-63.03M	-42.20M	-107.97M
Investing Cash Flow	48.55M	45.70M	-16.61M	-26.25M	-74.95M
Financing Cash Flow	25.62M	-92.36M	86.11M	20.35M	251.96M

Tycoon Group Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.30
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3390, the sentiment is Negative. The current price of 0.3 is below the 20-day moving average (MA) of 0.32, below the 50-day MA of 0.33, and below the 200-day MA of 1.72, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 36.29 is Neutral, neither overbought nor oversold. The STOCH value of 19.58 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3390.

Tycoon Group Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1612	74 Outperform	HK$623.49M	6.99	11.96%	4.32%	17.93%	36.82%
1518	64 Neutral	HK$341.67M	-7.31	8.55%	3.16%	-21.31%	-149.92%
1643	61 Neutral	HK$511.20M	20.70	2.00%	―	-15.96%	32.95%
1110	53 Neutral	HK$321.44M	54.08	6.50%	5.98%	-10.78%	-82.81%
3390	49 Neutral	HK$277.14M	76.19	-4.89%	22.58%	-1.68%	-111.10%
2393	41 Neutral	HK$298.19M	-1.70	199.66%	―	6.10%	-115.12%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Tycoon Group Holdings Limited Corporate Events

Tycoon Group Reports Revenue Growth but Faces Net Loss in 1H2025

Tycoon Group Holdings Limited reported a revenue increase of 17.3% for the first half of 2025, reaching HK$510.1 million. Despite this growth, the company experienced a net loss of HK$7.7 million, a significant decline from a net profit of HK$21.1 million in the same period the previous year. The gross profit margin saw a slight increase, but higher selling, distribution, and administrative expenses impacted overall profitability. The board decided not to declare an interim dividend, reflecting a cautious approach amid financial challenges.

The most recent analyst rating on (HK:3390) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Tycoon Group Holdings Limited stock, see the HK:3390 Stock Forecast page.

Tycoon Group Holdings to Review Interim Results and Dividend

Tycoon Group Holdings Limited has announced that its board of directors will hold a meeting on August 29, 2025, to consider and approve the interim results for the first half of 2025 and discuss the potential payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and strategic decisions, potentially impacting investor confidence and stakeholder interests.

Tycoon Group Issues Profit Warning Amid E-commerce Challenges

Tycoon Group Holdings Limited has issued a profit warning, expecting a loss of at least HK$7.0 million for the first half of 2025, compared to a profit of HK$24.2 million in the same period of 2024. This downturn is attributed to the challenges in the PRC e-commerce segment and increased expenses following the buy-back of Combo Win Asia Limited, which has led to additional non-cash expenses and operating costs. Despite these challenges, the company has managed to increase its revenue and maintain a steady gross profit margin.

Tycoon Group Holdings Limited Updates Nomination Committee Terms

Tycoon Group Holdings Limited has announced amendments to the terms of reference for its Nomination Committee, effective from July 1, 2025. These changes emphasize diversity and independence within the committee, requiring a minimum of three members, the majority being independent non-executive directors, and at least one member of a different gender. This move is likely to enhance the company’s governance practices and strengthen its commitment to diversity and independent oversight, potentially impacting its reputation positively among stakeholders.

Tycoon Group Holdings Limited Announces Board Restructuring

Tycoon Group Holdings Limited has announced changes to its board of directors, effective from July 1, 2025. The company, which is incorporated in the Cayman Islands, has appointed Mr. Wong Ka Chun Michael as the Chairman and Chief Executive Officer. The board will also include a mix of non-executive and independent non-executive directors, each serving on various committees such as Audit, Remuneration, Nomination, and Corporate Governance. This restructuring is likely to impact the company’s governance and strategic direction, potentially influencing its market positioning and stakeholder relations.

Tycoon Group Announces Board Changes with New Appointments

Tycoon Group Holdings Limited has announced changes in its board of directors, with the resignation of Mr. Hu Yang as a non-executive director due to work adjustments, effective July 1, 2025. The company has appointed Mr. Ng Kwan Ho and Mr. Cao Ran as non-executive directors, also effective from July 1, 2025. Mr. Ng brings extensive experience in marketing and brand management, having held senior positions in various companies, including JBM (Healthcare) Limited and Amway Hong Kong Limited. These changes are expected to bring new perspectives and expertise to the company’s board, potentially impacting its strategic direction and market positioning.